Meta-analysis of 31 studies (9416 patients with muscle-invasive bladder cancer having trimodal therapy): older age, ECOG PS 2+ (HR 2.47), impaired renal function, hydronephrosis, higher T stage, nodal disease and CIS were independently associated with worse overall survival.
Meta-analysisn = 9,416
Miyajima et al. Prognostic Factors of Trimodal Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis